Table 3.
Proportion of anti-glycans antibody positive subjects among the CD probands and the HFDRs
| |
ASCA positive |
ALCA positive |
ASCA or ALCA positive |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | % | 95% CI | p value | n | % | 95% CI | p value | n | % | 95% CI | p value | |
| CD probands (n=39) |
21 |
53.8 |
[38.6-68.4] |
p<0.0001 |
15 |
38.4 |
[24.9-54.1] |
p=0.0008 |
23 |
58.9 |
[43.4-72.9] |
p<0.0001 |
| HFDR (n=39) | 4 | 10.3 | [4.1-23.6] | 3 | 7.7 | [2.7-20.3] | 6 | 15.4 | [7.3-29.7] | |||
ASCA positivity was according to the 50 AU threshold and ALCA positivity according to the 60 AU threshold.